NICE has approved semaglutide (TA875) and liraglutide (TA664) for managing overweight and obesity in specific patient groups within specialist services, subject to prescribing criteria and monitoring requirements
Conditions associated with high B12 include liver disease, renal impairment, myeloproliferative disorders, and certain malignancies
Best for: fat metabolism support, weight management programs, GLP-1 medication adjunct (semaglutide, tirzepatide), liver health, insulin sensitization
At the biochemical level, NNMT regulates the conversion of nicotinic acid (NA) into 1-methylnicotinamide (1-MNA)
Curious to learn more about this vitamin
Preliminary findings from these studies suggest a tolerable oral dosage of approximately 100mg/kg in mice [1]